- Previous Close
0.7000 - Open
0.7000 - Bid 0.6500 x --
- Ask 0.7000 x --
- Day's Range
0.7000 - 0.7000 - 52 Week Range
0.5200 - 1.0400 - Volume
2,624 - Avg. Volume
14,014 - Market Cap (intraday)
63.013M - Beta (5Y Monthly) 1.08
- PE Ratio (TTM)
11.67 - EPS (TTM)
0.0600 - Earnings Date Dec 5, 2024 - Dec 9, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
cannara.ca--
Full Time Employees
August 31
Fiscal Year Ends
Healthcare
Sector
Drug Manufacturers - Specialty & Generic
Industry
Recent News: LOVE.V
View More
Performance Overview: LOVE.V
Trailing total returns as of 2024-11-01, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LOVE.V
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LOVE.V
View MoreValuation Measures
Market Cap
63.01M
Enterprise Value
106.43M
Trailing P/E
11.67
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.83
Price/Book (mrq)
0.77
Enterprise Value/Revenue
1.39
Enterprise Value/EBITDA
6.82
Financial Highlights
Profitability and Income Statement
Profit Margin
6.93%
Return on Assets (ttm)
3.78%
Return on Equity (ttm)
6.78%
Revenue (ttm)
76.69M
Net Income Avi to Common (ttm)
5.32M
Diluted EPS (ttm)
0.0600
Balance Sheet and Cash Flow
Total Cash (mrq)
5.46M
Total Debt/Equity (mrq)
59.78%
Levered Free Cash Flow (ttm)
-10.36M